Skip to content

Services
Product Development
Our Science
About
Contact

Services

Progress your programme with our unique combination of inhaled development expertise, formulation science and device technology. We offer a fully-integrated approach to support you in the development of your inhaled medicine.

Development

Services OverviewFormulationPharmaceutical analysisDevice platforms

Manufacturing

Process development & technical transferProduct manufacturing

Regulatory

Regulatory Services

About

Inhalation is our focus. With more than 20 years’ experience, we can help you succeed in bringing inhaled medicines to market.

Updates

About Vectura

Track RecordLeadership team

Financial Information

Vectura Fertin PharmaPMI OfferMeetings & VotingESG Strategy

Services Product Development Our Science About Contact

Development

Services Overview Formulation Pharmaceutical analysis Device platforms

Manufacturing

Process development & technical transfer Product manufacturing

Regulatory

Regulatory Services

Updates

About Vectura

Track Record Leadership team

Financial Information

Vectura Fertin Pharma PMI Offer Meetings & Voting ESG Strategy

Home » Investors archive » RNS email alerts

RNS email alerts

Updating you with the latest financial information

Services
Product Development
Our Science
About
Contact

Careers

Vectura Fertin Pharma
Accessibility
Commitment to inclusivity
Modern Slavery Act
Gender pay gap
Supplier Terms and Conditions
Tax strategy
Privacy Policy
Website Terms & Conditions
Cookie Statement
Site map
Breelib™ Instructions for Use
FOX^® Mobile Instructions for use

©2024 Vectura Group Ltd

Designed and Developed by Naked Ideas